Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alfa-2a with AZT and ddC in HIV
NCT00000754Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2a in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
interferon alfa-2a
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000754.